|
PHF23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.619000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.781200E-01 |
| Normal-vs-Stage2 |
7.679800E-02 |
| Normal-vs-Stage3 |
6.307400E-01 |
| Normal-vs-Stage4 |
6.452200E-01 |
| Stage1-vs-Stage2 |
1.372420E-01 |
| Stage1-vs-Stage3 |
6.079800E-01 |
| Stage1-vs-Stage4 |
5.613000E-01 |
| Stage2-vs-Stage3 |
1.063580E-01 |
| Stage2-vs-Stage4 |
7.071400E-01 |
| Stage3-vs-Stage4 |
4.644400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.121200E-01 |
| Normal-vs-AfricanAmerican |
4.470400E-01 |
| Normal-vs-Asian |
7.477200E-01 |
| Caucasian-vs-AfricanAmerican |
2.669600E-01 |
| Caucasian-vs-Asian |
6.403800E-01 |
| AfricanAmerican-vs-Asian |
6.156600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.904200E-01 |
| Normal-vs-Female |
6.200600E-01 |
| Male-vs-Female |
5.625400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.217400E-01 |
| Normal-vs-Extreme_Weight |
6.656200E-01 |
| Normal-vs-Obese |
4.394600E-01 |
| Normal-vs-Extreme_Obese |
7.890800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.104400E-01 |
| Normal_Weight-vs-Obese |
1.449560E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.804200E-01 |
| Extreme_Weight-vs-Obese |
2.271400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.834600E-01 |
| Obese-vs-Extreme_Obese |
9.923400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.811840E-01 |
| Normal-vs-Age(41-60Yrs) |
3.651800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.973400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.025700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.603200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.818340E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.688060E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.349900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.844800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.344200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.655800E-01 |
| Normal-VS-Type2 PRCC |
4.226400E-01 |
| Normal-VS-KIRP CIMP |
4.470000E-01 |
| Normal-VS-Unclassified PRCC |
7.853600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.261200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.357200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.840400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.991600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.136600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.114600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.188610E-01 |
| Normal-vs-N1 |
3.809600E-01 |
| Normal-vs-N2 |
1.088330E-02 |
| N0-vs-N1 |
5.550100E-02 |
| N0-vs-N2 |
2.483200E-01 |
| N1-vs-N2 |
5.688100E-02 |
|
|
